• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Argenx`s Biologic Vyvgart Hytrulo Receives Suppl Approval in US

    FDA

    Argenx Efgartigimod Alfa & Hyaluronidase-Qvfc Receives Suppl Approval in US

    FDA

    Argenx`s Biologic Vyvgart (efgartigimod) Receives Approval in the U.S.

    FDA

    Argenx`s Biologic Vyvgart Hytrulo (efgartigimod) Receives Approval in the U.S.

    FDA

    Argenx`s Biologic Vyvgart (Efgartigimod, Hyaluronidase) Receives Approval in the U.S.

    FDA

    Argenx`s Vyvgart (nirmatrelvir) Receives Approval in the Europe

    EMA

    Argenx`s Vyvgart (efgartigimod alfa) Receives Approval in Europe

    EMA

    Argenx`s Biologic Vyvgart (Efgartigimod Alfa) Receives Approval in the U.S.

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.